Sageworth Trust’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-115
Closed -$4K – 625
2021
Q4
$4K Sell
115
-385
-77% -$15.1K ﹤0.01% 457
2021
Q3
$24K Hold
500
– – ﹤0.01% 321
2021
Q2
$23K Buy
+500
New +$22.2K ﹤0.01% 364

Other funds holding NEO

Sageworth Trust's NEO Position: Q1 2022 in Review

Sageworth Trust sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 115 shares — an estimated $4K sold.

Sageworth Trust first reported a position in NEO in Q2 2021 and held it in 3 quarters. The position peaked at $24K in Q3 2021. 279 funds tracked by Wall St. Rank hold NEO as of Q1 2022.

  • Sageworth Trust reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
  • Sageworth Trust sold 115 NeoGenomics shares in Q1 2022, an estimated $4K.
  • Sageworth Trust first reported a position in NeoGenomics in Q2 2021 and held it in 3 quarters.
  • Sageworth Trust's NeoGenomics position peaked at $24K in Q3 2021.
  • 279 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.

Based on Sageworth Trust's 13F filing for Q1 2022, filed 6 May 2022.